RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms

ByQuantisnow·Wall Street's wire, on your screen.

CPIX· Cumberland Pharmaceuticals Inc.RDHL· Redhill Biopharma Ltd.

Health Care

RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms | Quantisnow